Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Cash from Investing Activities (2021 - 2024)

Historic Cash from Investing Activities for Verrica Pharmaceuticals (VRCA) over the last 4 years, with Q4 2024 value amounting to $8000.0.

  • Verrica Pharmaceuticals' Cash from Investing Activities rose 10352.42% to $8000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$19000.0, marking a year-over-year increase of 9251.97%. This contributed to the annual value of -$19000.0 for FY2024, which is 9475.14% up from last year.
  • Latest data reveals that Verrica Pharmaceuticals reported Cash from Investing Activities of $8000.0 as of Q4 2024, which was up 10352.42% from -$16000.0 recorded in Q3 2024.
  • Verrica Pharmaceuticals' 5-year Cash from Investing Activities high stood at $43.0 million for Q1 2022, and its period low was -$22.1 million during Q2 2021.
  • In the last 4 years, Verrica Pharmaceuticals' Cash from Investing Activities had a median value of $8000.0 in 2024 and averaged $3.5 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first surged by 29698.2% in 2022, then tumbled by 10336.1% in 2023.
  • Verrica Pharmaceuticals' Cash from Investing Activities (Quarter) stood at $4.0 million in 2021, then skyrocketed by 68.39% to $6.8 million in 2022, then crashed by 103.36% to -$227000.0 in 2023, then soared by 103.52% to $8000.0 in 2024.
  • Its Cash from Investing Activities stands at $8000.0 for Q4 2024, versus -$16000.0 for Q3 2024 and -$11000.0 for Q2 2024.